Clinical Trial Update: The Sleep Amyloid, Slow WAve Race and Ethnicity Study

View source ↗

Summary

The Sleep Amyloid, Slow Wake Race and Ethnicity Study (NCT03814603) sponsored by NYU Langone Health has completed, focusing on Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: NYU Langone Health | Conditions: Alzheimer Disease | Status: COMPLETED